Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jgar.2020.09.030 http://scihub22266oqcxt.onion/10.1016/j.jgar.2020.09.030 33075521!7568171!33075521     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33075521&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       J+Glob+Antimicrob+Resist 2020 ; 23 (?): 263-264 Nephropedia Template TP {{tp|p=33075521|t=2020. Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency |pdf=|usr=}}{{33075521}} gab.com Text Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency JO: J Glob Antimicrob Resist http://www.kidney.de/pget.php?&tw=1&pmid=33075521 #FOAvip Aim of this paper is to remind the risk of ototoxicity when using chloroquine and hydroxychloroquine, in particular as prophylactic agents against SARS-CoV-2, during the pandemic. Healthy subjects taking chloroquine and hydroxychloroquine as prophylactic agents against SARS-CoV-2, during the pandemic, should be screened periodically, at least by Otoacoustic Emissions (OAEs) in order to detect early manifestations of possible cochlear ototoxic damages. Twit Text FOAVip Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency ????J Glob Antimicrob Resist http://www.kidney.de/pget.php?&tw=1&pmid=33075521 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33075521 #FOAvip English Wikipedia <ref>{{Cite pmid|33075521}}</ref> Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency #MMPMID33075521 Ciorba A; Skarzynski PH; Pelucchi S; Hatzopoulos S J Glob Antimicrob Resist 2020[Dec]; 23 (?): 263-264 PMID33075521show ga Aim of this paper is to remind the risk of ototoxicity when using chloroquine and hydroxychloroquine, in particular as prophylactic agents against SARS-CoV-2, during the pandemic. Healthy subjects taking chloroquine and hydroxychloroquine as prophylactic agents against SARS-CoV-2, during the pandemic, should be screened periodically, at least by Otoacoustic Emissions (OAEs) in order to detect early manifestations of possible cochlear ototoxic damages. |*COVID-19 Drug Treatment[MESH] |Antiviral Agents/*adverse effects/therapeutic use[MESH] |Chloroquine/*adverse effects/therapeutic use/toxicity[MESH] |Humans[MESH] |Hydroxychloroquine/*adverse effects/therapeutic use[MESH] |Ototoxicity/*prevention & control/*virology[MESH] |Pandemics/prevention & control[MESH] |Risk Assessment[MESH]Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency (epmc).pdf DeepDyve Pubget Overpricing